ScreenerHero

MARI Marinomed Biotech AG

VIE · AT · Healthcare · Biotechnology · marinomed.com
4.000EUR0.00%Mkt Cap: 8.69M $P/E: 0.40

Marinomed Biotech AG operates as a biopharmaceutical company in Austria, other European countries, and internationally. Its lead products include Budesolv for the treatment of allergic rhinitis in late-stage clinical dev…

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$128.08BUSDP/E 29.4
MRNA
Moderna, Inc.
$78.44BUSD
REGN
Regeneron Pharmaceuticals, Inc.
$76.40BUSDP/E 18.4
ARGX
argenx SE
$57.03BUSDP/E 37.3
ARGX
argenx SE
$58.08BUSDP/E 35.4
UCB
UCB SA
$42.24BUSDP/E 18.0
RVMD
Revolution Medicines, Inc.
$43.05BUSD
ONC
BeOne Medicines AG
$41.41BUSDP/E 65.1
RPRX
Royalty Pharma plc
$32.80BUSDP/E 30.2
ALNY
Alnylam Pharmaceuticals, Inc.
$30.03BUSDP/E 37.8
ROIV
Roivant Sciences Ltd.
$25.10BUSD
BNTX
BioNTech SE
$23.93BUSD
INCY
Incyte Corporation
$22.99BUSDP/E 14.5
GMAB
Genmab A/S
$22.27BUSDP/E 30.7
GMAB
Genmab A/S
$22.54BUSDP/E 28.9
INSM
Insmed Incorporated
$22.22BUSD
ASND
Ascendis Pharma A/S
$15.03BUSDP/E 17.5
JAZZ
Jazz Pharmaceuticals plc
$15.01BUSDP/E 15.8
EXEL
Exelixis, Inc.
$14.48BUSDP/E 18.4
SMMT
Summit Therapeutics Inc.
$14.32BUSD

Key Statistics

Company
Market Cap8.69M USD
Enterprise Value19.53M USD
Revenue (TTM)8.65M USD
Gross Profit6.82M USD
Net Income (TTM)19.59M USD
Revenue/Share4.33 EUR
Last Price4.000 EUR
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees32
CountryAT
SectorHealthcare
IndustryBiotechnology
ISINATMARINOMED6
Valuation
P/E (Trailing)0.40
P/E (Forward)1.75
PEG—
EV/EBITDA374.19
EV/Revenue2.26
P/S1.00
P/B-1.04
EPS (TTM)10.10
EPS (Forward)2.29
52W Range
2.20010% of range21.00
52W High21.00 EUR
52W Low2.200 EUR
Profitability
Gross Margin81.52%
Oper. Margin-427.74%
EBITDA Margin0.60%
Profit Margin234.27%
ROE-255.75%
ROA302.77%
Growth
Revenue Growth-76.90%
Earnings Growth—
Cash Flow & Leverage
Operating CF-1.20M USD
CapEx (TTM)—
FCF Margin-23.98%
FCF Yield-23.87%
Net Debt11.53M USD
Net Debt/EBITDA220.92
Balance Sheet
Debt/Equity-1.62
Current Ratio0.25
Quick Ratio0.22
Book Value/Sh-3.83 EUR
Cash/Share0.52 EUR
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 EUR
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.2.00M
Float1.37M
Insiders23.83%
Institutions14.43%
Technical
SMA 504.585 (-12.8%)
SMA 20011.47 (-65.1%)
Beta-0.20
S&P 52W Chg16.45%
Avg Vol (30d)226
Avg Vol (10d)208
Technical Indicators
RSI (14)32.8
MACD-0.2630
MACD Signal-0.3034
MACD Hist.+0.0404
BB Upper4.695 EUR
BB Middle4.210 EUR
BB Lower3.725 EUR
BB Width23.05%
ATR (14)0.0902 EUR
Vol Ratio (20d)0.00x